Brief: Kalvista Pharmaceuticals Q2 Net Income USD -42.268 Million
Dec 05 (Reuters) - Kalvista Pharmaceuticals Q2 basic EPS USD -0.91. * Q2 operating expenses USD 45.811 million * Q2 operating income USD -45.811 million
Recent news on Kalvista Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 08:36 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Seagate, GE Healthcare, Bloom Energy